The promoter methylation levels of PDZK1 were lower in GBM specimens than in normal tissue specimens (Figure 2C), indicating that promoter DNA hypomethylation may be the reason for the high expression of PDZK1 in glioma. Here, PDZK1 is linked to central nervous system cancer.